Provided by Tiger Fintech (Singapore) Pte. Ltd.

Acumen Pharmaceuticals, Inc.

1.23
+0.02001.65%
Volume:203.33K
Turnover:249.34K
Market Cap:73.90M
PE:-0.89
High:1.27
Open:1.19
Low:1.18
Close:1.21
Loading ...

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
11 Nov 2024

Acumen Pharmaceuticals Inc expected to post a loss of 36 cents a share - Earnings Preview

Reuters
·
09 Nov 2024

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
08 Nov 2024

BRIEF-Acumen Pharmaceuticals Appoints Amy Schacterle As Chief Regulatory Officer & Head Of Quality

Reuters
·
06 Nov 2024

Acumen appoints Schacterle as Chief Regulatory Officer, Head of Quality

TIPRANKS
·
06 Nov 2024

Acumen Pharmaceuticals Appoints DR. Amy Schacterle as Chief Regulatory Officer & Head of Quality

THOMSON REUTERS
·
06 Nov 2024

Press Release: Acumen Pharmaceuticals Appoints Dr. Amy Schacterle as Chief Regulatory Officer & Head of Quality

Dow Jones
·
06 Nov 2024

Acumen Pharmaceuticals to Report Third Quarter Results on Nov. 12, 2024

GlobeNewswire
·
06 Nov 2024

Acumen Pharmaceuticals Presents Innovative Trial Screening Advancements Utilizing Ptau217 Assay in Phase 2 Study of Sabirnetug for Early Alzheimer’s Disease at the 17TH Annual Clinical Trials on Alzheimer’s Disease Conference

THOMSON REUTERS
·
31 Oct 2024

Acumen Pharmaceuticals Presents Innovative Trial Screening Advancements Utilizing pTau217 Assay in Phase 2 Study of Sabirnetug for Early Alzheimer’s Disease at the 17th Annual Clinical Trials on Alzheimer’s Disease Conference

GlobeNewswire
·
31 Oct 2024

BRIEF-Acumen Pharmaceuticals To Deliver Late-Breaking Presentation At 17Th Annual Clinical Trials On Alzheimer’S Disease (Ctad) Conference

Reuters
·
23 Oct 2024

Acumen Pharmaceuticals to Deliver Late-Breaking Presentation at 17TH Annual Clinical Trials on Alzheimer’s Disease (Ctad) Conference

THOMSON REUTERS
·
23 Oct 2024

Acumen Pharmaceuticals to Deliver Late-Breaking Presentation at 17th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference

GlobeNewswire
·
23 Oct 2024

3 US Penny Stocks With Market Caps Under $500M To Consider

Simply Wall St.
·
22 Oct 2024

Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV) and Acumen Pharmaceuticals (ABOS)

TIPRANKS
·
07 Oct 2024

Stifel Nicolaus Sticks to Their Buy Rating for Acumen Pharmaceuticals (ABOS)

TIPRANKS
·
04 Oct 2024